Title |
Clinical Integration of Next Generation Sequencing: A Policy Analysis
|
---|---|
Published in |
The Journal of Law, Medicine & Ethics, January 2021
|
DOI | 10.1111/jlme.12158 |
Pubmed ID | |
Authors |
David Kaufman, Margaret Curnutte, Amy L. McGuire |
Abstract |
Clinical next generation sequencing (NGS) technologies are challenging existing regulatory paradigms. We advocate a coordinate policy approach, which first requires a comprehensive understanding of the existing regulatory and legal structures. This paper introduces four key policy domains - including quality assurance, insurance coverage, intellectual property management, and data sharing - that must be addressed to ensure high quality clinical NGS. In bringing these policy issues into conversation through this special issue for the Journal of Law, Medicine & Ethics, we hope to lay the foundation for further discussion by a range of stakeholder groups with diverse and strong interests in the governance of NGS. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 7% |
Argentina | 1 | 3% |
Unknown | 26 | 90% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 8 | 28% |
Student > Master | 5 | 17% |
Other | 4 | 14% |
Student > Ph. D. Student | 4 | 14% |
Student > Bachelor | 4 | 14% |
Other | 2 | 7% |
Unknown | 2 | 7% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 11 | 38% |
Social Sciences | 6 | 21% |
Biochemistry, Genetics and Molecular Biology | 3 | 10% |
Medicine and Dentistry | 3 | 10% |
Economics, Econometrics and Finance | 1 | 3% |
Other | 2 | 7% |
Unknown | 3 | 10% |